(Q53299361)

13 May 2018

title

A phase I study of carboplatin concurrent with radiation in FIGO stage IIIB cervix uteri carcinoma. (English)

1 reference

13 May 2018

1 reference

Alfonso Duenas-Gonzalez

1

1 reference

13 May 2018

Lucely Cetina

2

1 reference

13 May 2018

Benito Sánchez

3

1 reference

13 May 2018

Ernesto Gomez

4

1 reference

13 May 2018

Lesbia Rivera

5

1 reference

13 May 2018

Jose Hinojosa

6

1 reference

13 May 2018

Carlos López-Graniel

7

1 reference

13 May 2018

Aaron Gonzalez-Enciso

8

1 reference

13 May 2018

Jaime de la Garza

9

1 reference

13 May 2018

language of work or name

English

0 references

publication date

1 August 2003

1 reference

13 May 2018

International Journal of Radiation Oncology Biology Physics

published in

1 reference

13 May 2018

volume

56

1 reference

13 May 2018

issue

5

1 reference

13 May 2018

page(s)

1361-1365

1 reference

13 May 2018

Epidemiology of cervical cancer

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900347-X

7 January 2021

Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900347-X

7 January 2021

Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900347-X

7 January 2021

Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900347-X

7 January 2021

Prognostic factors in advanced stage squamous cell cancer of the cervix

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900347-X

7 January 2021

Assessment of renal function in the early stages of nephrotoxicity induced by iodinated contrast media

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900347-X

7 January 2021

Carboplatin versus cisplatin in solid tumors: an analysis of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900347-X

7 January 2021

Review of the comparative pharmacology and clinical activity of cisplatin and carboplatin

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900347-X

7 January 2021

In vitro phase II comparison of the cytotoxicity of a novel platinum analog, nedaplatin (254-S), with that of cisplatin and carboplatin against fresh, human cervical cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900347-X

7 January 2021

A phase II trial of carboplatin for recurrent or metastatic squamous carcinoma of the uterine cervix: a Southwest Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900347-X

7 January 2021

A phase II study of carboplatin in advanced squamous cell carcinoma of the cervix (a Gynecologic Oncology Group Study)

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900347-X

7 January 2021

Phase II trial of carboplatin or iproplatin in cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900347-X

7 January 2021

A randomized comparative trial of carboplatin and iproplatin in advanced squamous carcinoma of the uterine cervix: a Gynecologic Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900347-X

7 January 2021

Carboplatin as a potentiator of radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900347-X

7 January 2021

Production of DNA double-strand breaks by interactions between carboplatin and radiation: a potential mechanism for radiopotentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900347-X

7 January 2021

Twice-weekly paclitaxel and weekly carboplatin with concurrent thoracic radiation followed by carboplatin/paclitaxel consolidation for stage III non-small-cell lung cancer: a California Cancer Consortium phase II trial

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900347-X

7 January 2021

Chemotherapy as a part of each treatment fraction in a twice-a-day hyperfractionated schedule: a new chemoradiotherapy approach for advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900347-X

7 January 2021

Simultaneous carboplatin and radiotherapy for all stages of head and neck squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900347-X

7 January 2021

Phase II study of accelerated fractionation radiation therapy with carboplatin followed by PCV chemotherapy for the treatment of anaplastic gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900347-X

7 January 2021

Daily low-dose carboplatin as a radiation sensitizer for newly diagnosed malignant glioma.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900347-X

7 January 2021

Phase II trial of continuous infusion carboplatin, 5-fluorouracil, and radiotherapy for localized cancer of the esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900347-X

7 January 2021

Carboplatin as a radiation sensitizer in locally advanced cervical cancer: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900347-X

7 January 2021

Concomitant irradiation and dose-escalating carboplatin for locally advanced carcinoma of the uterine cervix: an updated report

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900347-X

7 January 2021

Continuous infusion of carboplatin during conventional radiotherapy treatment in advanced squamous carcinoma of the cervix uteri IIB-IIIB (UICC). A phase I/II and pharmacokinetic study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900347-X

7 January 2021

Concurrent carboplatin/5FU and radiotherapy compared to radiotherapy alone in locally advanced cervical carcinoma: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900347-X

7 January 2021

Concurrent carboplatin/5-fluorouracil and radiotherapy for recurrent cervical carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900347-X

7 January 2021

High-Dose Cisplatin in Hypertonic Saline

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900347-X

7 January 2021

Carboplatin dosage: prospective evaluation of a simple formula based on renal function

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900347-X

7 January 2021

Concomitant chemoradiation versus neoadjuvant chemotherapy in locally advanced cervical carcinoma: results from two consecutive phase II studies

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900347-X

7 January 2021

Radiation therapy alone or with concurrent low-dose daily either cisplatin or carboplatin in locally advanced unresectable squamous cell carcinoma of the head and neck: a prospective randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900347-X

7 January 2021

10.1016/S0360-3016(03)00347-X

Identifiers

DOI

1 reference

13 May 2018

1 reference

13 May 2018